Ersöz M, Yildirmak M T, Gedik H, Simşek F, Kantürk A, Iris N E, Dinç E
Department of Infectious Diseases and Clinical Microbiology, Minsitry of Health Okmeydani Training and Research Hospital, Istanbul, Turkey.
West Indian Med J. 2012 Sep;61(6):592-7.
This was to evaluate the history, clinical and laboratory findings, outcome and prognosis of patients with tuberculous meningitis (TBM).
Between 1998 and 2009, 60 patients with TBM were evaluated, retrospectively.
Overall, 60 patients were selected, of which 33 (55%) were male. The patients' ages ranged from 14 to 62 years. In the majority of the patients, disease was in an advanced stage on admission (66% in stage III according to the British Research Council neurological criteria). The rate of complications was highest among patients in stages II and III with an overall mortality rate of 6.6% (n = 2 of stage II patients and n = 2 of stage III patients).
Earlier admission of the patients with TBM could provide better outcomes with regard to sequelae and mortality. Fatal cases presented with rapid deterioration and were refractory to treatment.
评估结核性脑膜炎（TBM）患者的病史、临床及实验室检查结果、结局和预后。
回顾性评估1998年至2009年间60例TBM患者。
总共入选60例患者，其中33例（55%）为男性。患者年龄在14至62岁之间。大多数患者入院时病情已处于晚期（根据英国研究委员会神经学标准，66%处于III期）。II期和III期患者的并发症发生率最高，总死亡率为6.6%（II期患者2例，III期患者2例）。
TBM患者更早入院在后遗症和死亡率方面可带来更好的结局。致命病例病情迅速恶化且治疗无效。
Zotero 插件